| Original language | English |
|---|---|
| Pages (from-to) | e435-e436 |
| Journal | Critical Care Medicine |
| Volume | 47 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 1 2019 |
Bibliographical note
Funding Information:Drs. McCurdy, Khanna, and Busse received funding from La Jolla Pharmaceuticals. Drs. McCurdy and Khanna disclosed off-label product use of angiotensin II in resuscitation.
Funding
Drs. McCurdy, Khanna, and Busse received funding from La Jolla Pharmaceuticals. Drs. McCurdy and Khanna disclosed off-label product use of angiotensin II in resuscitation.
| Funders |
|---|
| La Jolla Pharmaceuticals |
ASJC Scopus subject areas
- Critical Care and Intensive Care Medicine
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver